Cargando…

Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients

Cardiovascular diseases (CVDs) remain a significant cause of death in hemodialysis (HD) patients. To explore their associations, we examine the role of soluble urokinase-type plasminogen activator receptor (suPAR) in arterial stiffness in chronic HD patients. From June to August 2020, we recruited 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei-Chen, Wu, Tsung-Jui, Wang, Chih-Hsien, Hsieh, Yi-Jen, Hsu, Bang-Gee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051056/
https://www.ncbi.nlm.nih.gov/pubmed/36983652
http://dx.doi.org/10.3390/jpm13030470
_version_ 1785014782237081600
author Lin, Wei-Chen
Wu, Tsung-Jui
Wang, Chih-Hsien
Hsieh, Yi-Jen
Hsu, Bang-Gee
author_facet Lin, Wei-Chen
Wu, Tsung-Jui
Wang, Chih-Hsien
Hsieh, Yi-Jen
Hsu, Bang-Gee
author_sort Lin, Wei-Chen
collection PubMed
description Cardiovascular diseases (CVDs) remain a significant cause of death in hemodialysis (HD) patients. To explore their associations, we examine the role of soluble urokinase-type plasminogen activator receptor (suPAR) in arterial stiffness in chronic HD patients. From June to August 2020, we recruited 135 chronic HD patients. The arterial stiffness group included patients with a carotid–femoral pulse-wave velocity (cfPWV) of >10 m/s. Fifty-five HD patients (40.7%) were in the arterial stiffness group. They had a higher prevalence of diabetes (p = 0.001) and hypertension (p = 0.039), were older (p = 0.007) and had higher aortic systolic blood pressure (p = 0.034), brachial systolic blood pressure (p = 0.025), glucose (p = 0.019), C-reactive protein (p = 0.039), and AIx75 (p = 0.003) and suPAR (p < 0.001) levels than the control group. After we performed multivariable logistic regression analysis, except age and glucose, serum suPAR (odds ratio [OR]: 2.05; 95% confidence interval [CI]: 1.48–2.70, p < 0.001) was independently associated with arterial stiffness in chronic HD patients. In the multivariable linear regression analysis, suPAR positively correlated with cfPWV (β = 0.475, p < 0.001) and could serve as a biomarker for arterial stiffness development in patients undergoing HD.
format Online
Article
Text
id pubmed-10051056
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100510562023-03-30 Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients Lin, Wei-Chen Wu, Tsung-Jui Wang, Chih-Hsien Hsieh, Yi-Jen Hsu, Bang-Gee J Pers Med Article Cardiovascular diseases (CVDs) remain a significant cause of death in hemodialysis (HD) patients. To explore their associations, we examine the role of soluble urokinase-type plasminogen activator receptor (suPAR) in arterial stiffness in chronic HD patients. From June to August 2020, we recruited 135 chronic HD patients. The arterial stiffness group included patients with a carotid–femoral pulse-wave velocity (cfPWV) of >10 m/s. Fifty-five HD patients (40.7%) were in the arterial stiffness group. They had a higher prevalence of diabetes (p = 0.001) and hypertension (p = 0.039), were older (p = 0.007) and had higher aortic systolic blood pressure (p = 0.034), brachial systolic blood pressure (p = 0.025), glucose (p = 0.019), C-reactive protein (p = 0.039), and AIx75 (p = 0.003) and suPAR (p < 0.001) levels than the control group. After we performed multivariable logistic regression analysis, except age and glucose, serum suPAR (odds ratio [OR]: 2.05; 95% confidence interval [CI]: 1.48–2.70, p < 0.001) was independently associated with arterial stiffness in chronic HD patients. In the multivariable linear regression analysis, suPAR positively correlated with cfPWV (β = 0.475, p < 0.001) and could serve as a biomarker for arterial stiffness development in patients undergoing HD. MDPI 2023-03-04 /pmc/articles/PMC10051056/ /pubmed/36983652 http://dx.doi.org/10.3390/jpm13030470 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lin, Wei-Chen
Wu, Tsung-Jui
Wang, Chih-Hsien
Hsieh, Yi-Jen
Hsu, Bang-Gee
Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
title Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
title_full Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
title_fullStr Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
title_full_unstemmed Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
title_short Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
title_sort association between serum soluble urokinase-type plasminogen activator receptor level and arterial stiffness in chronic hemodialysis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051056/
https://www.ncbi.nlm.nih.gov/pubmed/36983652
http://dx.doi.org/10.3390/jpm13030470
work_keys_str_mv AT linweichen associationbetweenserumsolubleurokinasetypeplasminogenactivatorreceptorlevelandarterialstiffnessinchronichemodialysispatients
AT wutsungjui associationbetweenserumsolubleurokinasetypeplasminogenactivatorreceptorlevelandarterialstiffnessinchronichemodialysispatients
AT wangchihhsien associationbetweenserumsolubleurokinasetypeplasminogenactivatorreceptorlevelandarterialstiffnessinchronichemodialysispatients
AT hsiehyijen associationbetweenserumsolubleurokinasetypeplasminogenactivatorreceptorlevelandarterialstiffnessinchronichemodialysispatients
AT hsubanggee associationbetweenserumsolubleurokinasetypeplasminogenactivatorreceptorlevelandarterialstiffnessinchronichemodialysispatients